These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 25913864)

  • 21. Drug discovery for malaria: a very challenging and timely endeavor.
    Gelb MH
    Curr Opin Chem Biol; 2007 Aug; 11(4):440-5. PubMed ID: 17761335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents.
    de Souza NB; Carmo AM; Lagatta DC; Alves MJ; Fontes AP; Coimbra ES; da Silva AD; Abramo C
    Biomed Pharmacother; 2011 Jul; 65(4):313-6. PubMed ID: 21704476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seeking the Elusive Long-Acting Ozonide: Discovery of Artefenomel (OZ439).
    Kim HS; Hammill JT; Guy RK
    J Med Chem; 2017 Apr; 60(7):2651-2653. PubMed ID: 28296396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antimalarial resistome - finding new drug targets and their modes of action.
    Carolino K; Winzeler EA
    Curr Opin Microbiol; 2020 Oct; 57():49-55. PubMed ID: 32682267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ferrocene-based antimalarials.
    Roux C; Biot C
    Future Med Chem; 2012 Apr; 4(6):783-97. PubMed ID: 22530641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.
    Ashton TD; Devine SM; Möhrle JJ; Laleu B; Burrows JN; Charman SA; Creek DJ; Sleebs BE
    J Med Chem; 2019 Dec; 62(23):10526-10562. PubMed ID: 31385706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resisting resistance: is there a solution for malaria?
    Verlinden BK; Louw A; Birkholtz LM
    Expert Opin Drug Discov; 2016; 11(4):395-406. PubMed ID: 26926843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Structural Chemistry Perspective on the Antimalarial Properties of Thiosemicarbazone Metal Complexes.
    Summers KL
    Mini Rev Med Chem; 2019; 19(7):569-590. PubMed ID: 30324878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins.
    Madhav H; Hoda N
    Eur J Med Chem; 2021 Jan; 210():112955. PubMed ID: 33131885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trioxaferroquines as new hybrid antimalarial drugs.
    Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
    J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current status of antimalarial drug research with special reference to application of QSAR models.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):91-128. PubMed ID: 25543681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug targets for resistant malaria: Historic to future perspectives.
    Kumar S; Bhardwaj TR; Prasad DN; Singh RK
    Biomed Pharmacother; 2018 Aug; 104():8-27. PubMed ID: 29758416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisquinoline antimalarials: their role in malaria chemotherapy.
    Raynes K
    Int J Parasitol; 1999 Mar; 29(3):367-79. PubMed ID: 10333319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in antimalarial drug development.
    Vangapandu S; Jain M; Kaur K; Patil P; Patel SR; Jain R
    Med Res Rev; 2007 Jan; 27(1):65-107. PubMed ID: 16700012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
    Schlitzer M
    ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antimalarial pipeline--an update.
    Schrader FC; Barho M; Steiner I; Ortmann R; Schlitzer M
    Int J Med Microbiol; 2012 Oct; 302(4-5):165-71. PubMed ID: 22898490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria chemotherapy: recent advances in drug development.
    Gemma S; Travagli V; Savini L; Novellino E; Campiani G; Butini S
    Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):195-225. PubMed ID: 20738242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the Recent Pioneering Developments of Small Molecules in Antimalarial Drug Armamentarium: A Chemistry Prospective Appraisal.
    Bagratee T; Prawlall R; Ndlovu T; Sibisi S; Ndadane S; Shaik BB; Palkar MB; Gampa R; Karpoormath R
    Chem Biodivers; 2024 Aug; 21(8):e202400460. PubMed ID: 38759144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinoline-Based Hybrid Compounds with Antimalarial Activity.
    Nqoro X; Tobeka N; Aderibigbe BA
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29257067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.
    Tang YQ; Ye Q; Huang H; Zheng WY
    Curr Mol Med; 2020; 20(8):583-592. PubMed ID: 32031068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.